HCA Healthcare, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.51B | $3.79B |
| Depreciation & Amortization | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B |
| Depreciation | $3.51B | $3.29B | $3.05B | $2.94B | $2.83B | $2.69B | $2.58B | $2.26B |
| Amortization | $12.0M | $16.0M | $20.0M | $44.0M | $25.0M | $26.0M | — | — |
| Stock-Based Compensation | $401.0M | $360.0M | $262.0M | $341.0M | $440.0M | $362.0M | $347.0M | $268.0M |
| Net Cash from Operating Activities | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B |
| Investing Activities | ||||||||
| Capital Expenditures | $4.94B | $4.88B | $4.74B | $4.40B | $3.58B | $2.84B | $4.16B | $3.57B |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B |
| Financing Activities | ||||||||
| Dividends Paid | $679.0M | $690.0M | $661.0M | $653.0M | $624.0M | $153.0M | $550.0M | $487.0M |
| Stock Repurchases | $10.07B | $6.04B | $3.81B | $7.00B | $8.22B | $441.0M | $1.03B | $1.53B |
| Net Cash from Financing Activities | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B |
| Net Change in Cash | $-893.0M | $998.0M | $27.0M | $-543.0M | $-342.0M | $1.17B | $119.0M | $-230.0M |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B |